⏳ Fetching live dividend data...
Home › Calculator › CDXC Dividend Calculator 2026
ChromaDex Corporation · NASDAQ
Price: $7.87 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CDXC → $5458277.98M in 10 years · $453,115,278,569.39/month
ChromaDex Corporation is a bioscience enterprise committed to advancing healthy aging. The company's operations are segmented into three primary areas: Consumer Products, Ingredients, and Analytical Reference Standards and Services. Its research efforts largely concentrate on nicotinamide adenine dinucleotide (NAD+). Under its Consumer Products division, ChromaDex provides finished dietary supplements, which incorporate its proprietary ingredients, directly to consumers and through distributors. A flagship offering is TRU NIAGEN, a supplement featuring NIAGEN, the company's proprietary nicotinamide riboside (an NAD+ precursor) as its active component. The Ingredients segment is responsible for the development and commercialization of specialized ingredient technologies. It supplies these unique raw materials, including NIAGEN, to other manufacturers for use in their consumer products. Another significant ingredient is IMMULINA, composed of Braun-type lipoproteins and spirulina extracts, which is designed to support immune system function. Additionally, ChromaDex offers analytical reference standards and services. These products are vital for performing quality control checks on raw materials and finished goods within industries such as dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceuticals. TRU NIAGEN products reach consumers via multiple channels, including ChromaDex's dedicated e-commerce site, TRUNIAGEN.com, as well as Amazon and other online marketplaces. Distribution also extends to specialty retailers and directly to healthcare practitioners within the United States. ChromaDex Corporation's main office is located in Los Angeles, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CDXC position with:
Real after-tax yield depends on where you live and how you hold CDXC.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 25.41% | 22.61% | $2,541 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 21.60% | 18.80% | $2,160 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 20.33% | 17.53% | $2,033 / yr |
| 🇬🇧 UK ISA | 0% | 25.41% | 22.61% | $2,541 / yr |
| 🇬🇧 UK Taxable | 8.75% | 23.19% | 20.39% | $2,319 / yr |
| 🇨🇦 TFSA | 0% | 25.41% | 22.61% | $2,541 / yr |
| 🇨🇦 CA Taxable | 25% | 19.06% | 16.26% | $1,906 / yr |
| 🇦🇺 Super (pension) | 15% | 21.60% | 18.80% | $2,160 / yr |
| 🇦🇺 AU Taxable | 30% | 17.79% | 14.99% | $1,779 / yr |
| 🇩🇪 DE Taxable | 26.375% | 18.71% | 15.91% | $1,871 / yr |
| 🇫🇷 FR Taxable | 30% | 17.79% | 14.99% | $1,779 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
CDXC pays quarterly — 4 times per year. Next ex-div: TBD.
How CDXC compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CDXC sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2025-03-07 | 273 | $7.86 | $2.1K | ||
| A-Award | 2025-02-25 | 1,518,600 | — | — | ||
| A-Award | 2025-02-12 | 19,691 | $5.48 | $107.9K | ||
| A-Award | 2025-02-12 | 17,230 | $5.48 | $94.4K | ||
| A-Award | 2025-02-12 | 492,278 | $5.48 | $2.70M | ||
| M-Exempt | 2024-12-13 | 50,001 | $3.66 | $183.0K | ||
| Sale | 2024-12-13 | 37,161 | $6.19 | $230.0K | ||
| M-Exempt | 2024-12-13 | 50,001 | $3.66 | $183.0K | ||
| Buy | 2024-11-22 | 2,907.197 | $7.36 | $21.4K | ||
| Other | 2025-07-22 | 75,877 | $2.97 | $225.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CDXC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
ChromaDex Corporation (CDXC) is currently trading at $7.87, 41% below its 52-week high. The current dividend yield is 25.41% based on an annual payout of $2.00 per share.
ChromaDex Corporation (CDXC) is a healthcare stock currently trading at $7.87 with a dividend yield of 25.41%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →